can semaglutide cause intestinal blockage Weighing the Risks: Small Bowel Obstruction Associated With Use in the Postoperative Abdomen semaglutide and intestinal obstruction GLP-1

The expiration date is set at the point where any of these parameters first falls outside acceptable limits, with a safety margin

From the phase 3 trials at the 9 mg and 12 mg doses: Nausea: 38.1% (9 mg) to 43.2% (12 mg) versus 10.7% with placebo Diarrhea: 34.7% (9 mg) to 33.1% (12 mg) versus 13.4% with placebo Constipation: 21.8% (9 mg) to 25.0% (12 mg) versus 8.7% with placebo Vomiting: 20.4% (9 mg) to 20.9% (12 mg) Compare those numbers to Mounjaro and the difference is clear

Results were similar when analyzed post hoc with study site as a random effect, with an estimated mean weight change from week 20 to week 68 of 7.9% with continued semaglutide vs +6.9% with placebo (difference, 14.7 [95% CI, 16.1 to 13.4] percentage points

Alternative programs also exist, such as the low-insulin weight loss program

It operates by upping secretion of insulin and slowing down the emptying of the stomach

Treatment duration depends on your medical indication, individual response, and health goals